Guam
Diabetes country report 2011 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Guam (GU)
| 2011 | 10.3 thousand |
| 2024 | 24.4 thousand |
| 2050 | 27.4 thousand |
Guam is one of the 37 countries and territories in the Western Pacific Region.
Data source(s) used for the diabetes estimates in adults:
- Ichiho HM, Gillan JW, Aitaoto N. Hawaii J Med Public Health. 2013 May;72(5 Suppl 1):68-76. PMID:23900408
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | - | 10.3 | 24.4 | 27.4 |
| Age-standardised prevalence of diabetes, % | - | 8.6 | 20.3 | 22.4 |
| Proportion of people with undiagnosed diabetes, % | - | - | 32.9 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 8.0 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 5.5 | 6.2 |
| Age-standardised prevalence of IFG, % | - | - | 5.0 | 5.0 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 14.9 | 9.4 | 10.5 |
| Age-standardised prevalence of IGT, % | - | 12.6 | 7.9 | 8.6 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | - | 294.0 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 35.9 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | - | - |
| Total diabetes-related health expenditure, ID million | - | - | - | - |
| Diabetes-related health expenditure per person, USD | - | - | - | - |
| Diabetes-related health expenditure per person, ID | - | - | - | - |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 7.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 1.7 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | - | 114.5 | 111.1 | 126.1 |
| Population of children and adolescents (0-19 y) | - | - | 55,633.5 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | - |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | - |
| Population of children and adolescents (0-19 y) | - |
